Nurol Gayrimenkul Yatirim Ortakligi AS
IST:NUGYO.E
Nurol Gayrimenkul Yatirim Ortakligi AS
IST:NUGYO.E
Price:
9.35
TRY
2.52%
Market Closed
Market Cap:
₺3.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nurol Gayrimenkul Yatirim Ortakligi AS
IST:NUGYO.E
|
TR |
|
PVR INOX Ltd
BSE:532689
|
IN |
|
Marston's PLC
LSE:MARS
|
UK |
|
Helix Biopharma Corp
TSX:HBP
|
CA |
|
Y
|
Yubo International Biotech Ltd
OTC:YBGJ
|
CN |
|
Concordia Financial Group Ltd
TSE:7186
|
JP |
|
Melodiol Global Health Ltd
ASX:ME1
|
AU |
Income Statement
Earnings Waterfall
Nurol Gayrimenkul Yatirim Ortakligi AS
Nurol Gayrimenkul Yatirim Ortakligi AS
Income Statement
Nurol Gayrimenkul Yatirim Ortakligi AS
Nurol Gayrimenkul Yatirim Ortakligi AS
Currency: TRY
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
202
|
205
|
196
|
204
|
215
|
209
|
209
|
323
|
277
|
248
|
225
|
102
|
107
|
133
|
140
|
125
|
115
|
0
|
0
|
0
|
|
| Revenue |
377
N/A
|
403
+7%
|
385
-4%
|
484
+26%
|
494
+2%
|
1 021
+107%
|
1 119
+10%
|
2 068
+85%
|
932
-55%
|
372
-60%
|
224
-40%
|
195
-13%
|
554
+184%
|
1 193
+115%
|
1 440
+21%
|
1 673
+16%
|
1 440
-14%
|
815
-43%
|
661
-19%
|
759
+15%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(121)
|
(126)
|
(117)
|
(127)
|
(110)
|
(184)
|
(176)
|
(1 031)
|
(150)
|
(56)
|
(47)
|
(46)
|
(262)
|
(575)
|
(714)
|
(812)
|
(699)
|
(395)
|
(298)
|
(393)
|
|
| Gross Profit |
256
N/A
|
277
+8%
|
268
-3%
|
358
+33%
|
384
+7%
|
837
+118%
|
944
+13%
|
1 038
+10%
|
782
-25%
|
317
-59%
|
177
-44%
|
149
-16%
|
292
+96%
|
619
+112%
|
725
+17%
|
861
+19%
|
741
-14%
|
420
-43%
|
364
-13%
|
365
+0%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(114)
|
(127)
|
(113)
|
(156)
|
(87)
|
(346)
|
(411)
|
(962)
|
(26)
|
243
|
301
|
(239)
|
432
|
149
|
27
|
(827)
|
(669)
|
(436)
|
(386)
|
(406)
|
|
| Selling, General & Administrative |
(135)
|
(143)
|
(129)
|
(161)
|
(171)
|
(435)
|
(498)
|
(924)
|
(465)
|
(201)
|
(142)
|
(223)
|
(312)
|
(602)
|
(721)
|
(850)
|
(763)
|
(525)
|
(480)
|
(398)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(1)
|
(1)
|
0
|
(4)
|
(4)
|
(6)
|
(7)
|
(7)
|
(5)
|
(5)
|
(5)
|
(8)
|
|
| Other Operating Expenses |
21
|
16
|
17
|
6
|
87
|
91
|
89
|
(35)
|
440
|
445
|
443
|
(12)
|
748
|
758
|
755
|
29
|
99
|
94
|
99
|
0
|
|
| Operating Income |
142
N/A
|
151
+6%
|
156
+3%
|
202
+30%
|
297
+47%
|
491
+65%
|
532
+8%
|
76
-86%
|
756
+897%
|
560
-26%
|
478
-15%
|
(89)
N/A
|
724
N/A
|
768
+6%
|
752
-2%
|
34
-96%
|
72
+115%
|
(16)
N/A
|
(22)
-38%
|
(40)
-81%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(295)
|
(296)
|
(232)
|
(295)
|
(354)
|
(313)
|
(280)
|
(294)
|
116
|
175
|
184
|
1 223
|
64
|
4
|
(20)
|
30
|
(52)
|
(27)
|
(17)
|
(329)
|
|
| Non-Reccuring Items |
(3)
|
(1)
|
0
|
(2)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(5)
|
(7)
|
(7)
|
(8)
|
(8)
|
(12)
|
(11)
|
780
|
(14)
|
(20)
|
(35)
|
(36)
|
49
|
177
|
223
|
226
|
168
|
49
|
27
|
14
|
|
| Pre-Tax Income |
(161)
N/A
|
(153)
+5%
|
(84)
+45%
|
(104)
-23%
|
(65)
+37%
|
166
N/A
|
241
+45%
|
535
+121%
|
858
+61%
|
715
-17%
|
628
-12%
|
1 098
+75%
|
836
-24%
|
949
+13%
|
955
+1%
|
290
-70%
|
188
-35%
|
6
-97%
|
(12)
N/A
|
(356)
-2 823%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(63)
|
(261)
|
(269)
|
(238)
|
(121)
|
|
| Income from Continuing Operations |
(161)
|
(153)
|
(84)
|
(104)
|
(65)
|
166
|
241
|
535
|
858
|
715
|
628
|
1 098
|
836
|
949
|
955
|
228
|
(73)
|
(263)
|
(250)
|
(476)
|
|
| Net Income (Common) |
(161)
N/A
|
(153)
+5%
|
(84)
+45%
|
(104)
-23%
|
(65)
+37%
|
166
N/A
|
241
+45%
|
535
+121%
|
858
+61%
|
715
-17%
|
628
-12%
|
1 098
+75%
|
836
-24%
|
949
+13%
|
955
+1%
|
228
-76%
|
(73)
N/A
|
(263)
-259%
|
(250)
+5%
|
(476)
-91%
|
|
| EPS (Diluted) |
-0.52
N/A
|
-0.5
+4%
|
-0.27
+46%
|
-0.34
-26%
|
-0.21
+38%
|
0.5
N/A
|
0.73
+46%
|
1.63
+123%
|
2.56
+57%
|
2.13
-17%
|
1.87
-12%
|
3.27
+75%
|
2.49
-24%
|
2.83
+14%
|
2.85
+1%
|
0.68
-76%
|
-0.22
N/A
|
-0.78
-255%
|
-0.74
+5%
|
-1.42
-92%
|
|
Switch to:
Switch to:
See Also
Discover More
